三组之间基本数据比较
包含108名慢性牙周炎患者三种漱口水治疗的基线数据、成本、牙周指标和EQ-5D-3L效用值,用于经济性分析。

基本信息
资源简介
三组之间基本数据比较
【数据集背景】
本数据集源站标题为《Comparison of basic data among the three groups.》。源站首次发布:2024-05-08。
【数据内容】
源站原始描述:Objective This study aimed to investigate the economics of three different gargles in the treatment of chronic periodontitis. Methods A total of 108 patients with periodontitis received one of the following three gargles: xipayi, compound chlorhexidine, or Kangfuxin gargle. The basic information of the patients, the costs of the gargles, the periodontal indexes before and after treatment, and the scores of the 3-level version of the EuroQol Five Dimensions Questionnaire were collected. The cost-…
【数据结构与技术规格】
文件数 1 个,合计 5.63 KB。Table 1.xls:application/vnd.ms-excel,5.63 KB。数据集 DOI:10.1371/journal.pone.0302592.t001。
【主题与分类】
源站学科分类:Biochemistry、Microbiology、Pharmacology、Biotechnology、Evolutionary Biology、Ecology。主题标签:adjusted life years、periodontitis received one、compound chlorhexidine group、three different gargles、following three gargles、compound chlorhexidine、three groups、various gargles、periodontitis patients、xlink ">。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://plos.figshare.com/articles/dataset/Comparison_of_basic_data_among_the_three_groups_/25775130
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Chen, Xin; Niu, Wenzhi; Hu, Guangyu; Chen, Changfeng (2024). Comparison of basic data among the three groups.. PLOS ONE. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Comparison of basic data among the three groups.
- DOI:10.1371/journal.pone.0302592.t001
- 发布日期:2024-05-08
- 文件数:1 个
- 文件总体积:5.63 KB
- 源站页面:https://plos.figshare.com/articles/dataset/Comparison_of_basic_data_among_the_three_groups_/25775130
命令行下载
curl -L -o "Table 1.xls" "https://ndownloader.figshare.com/files/46183296"
文件清单
Table 1.xls(5.63 KB)
文件总体积 5.63 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Objective
This study aimed to investigate the economics of three different gargles in the treatment of chronic periodontitis.
Methods
A total of 108 patients with periodontitis received one of the following three gargles: xipayi, compound chlorhexidine, or Kangfuxin gargle. The basic information of the patients, the costs of the gargles, the periodontal indexes before and after treatment, and the scores of the 3-level version of the EuroQol Five Dimensions Questionnaire were collected. The cost-effectiveness and cost-utility of the various gargles were determined.
Results
The cost-effectiveness ratios (CER) of the three groups after treatment were 1828.75, 1573.34, and 1876.92 RMB, respectively. The utility values before treatment were 0.92, 0.90, and 0.91, respectively, and the utility values after treatment were 0.98, 0.98, and 0.97, respectively. The cost-utility ratios (CURs) were 213.43, 195.61, and 301.53 RMB, respectively.
Conclusions
For each increase in effective rate and quality-adjusted life years, the treatment cost of periodontitis patients was lower than the gross domestic product per capita of Jiangsu Province, indicating that the treatment cost is completely worth it. The CER and CUR results were the same, and the compound chlorhexidine group was the lowest, demonstrating that when the same therapeutic effect was achieved, it cost the least.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.1371/journal.pone.0302592.t001(source: https://plos.figshare.com/articles/dataset/Comparison_of_basic_data_among_the_three_groups_/25775130)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




